Dicloxacillin: Difference between revisions
MEDMOS |
Available forms, contraindications |
||
(3 intermediate revisions by the same user not shown) | |||
Line 48: | Line 48: | ||
| StdInChIKey = YFAGHNZHGGCZAX-JKIFEVAISA-N |
| StdInChIKey = YFAGHNZHGGCZAX-JKIFEVAISA-N |
||
}} |
}} |
||
'''Dicloxacillin''' |
'''Dicloxacillin''' (INN) is a narrow-spectrum β-Lactam antibiotic of the penicillin class. It is used to treat infections caused by susceptible Gram-positive bacteria.<ref name=":0">Product Information: DICLOXACILLIN SODIUM-dicloxacillin sodium capsule. Teva Pharmaceuticals USA Inc, Revised 8/2015</ref> It is active against beta-lactamase-producing organisms such as ''Staphylococcus aureus'',<ref>Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F (2006). "''In vitro'' activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant ''Staphylococcus'' spp. strains". ''Ann. Clin. Microbiol. Antimicrob.'' '''5''': 25. doi:10.1186/1476-0711-5-25. PMC 1617116.<nowiki>PMID 17034644</nowiki>.</ref> which would otherwise be resistant to most penicillins. Dicloxacillin is available under a variety of trade names including Diclocil (BMS). |
||
==Medical uses== |
==Medical uses== |
||
Dicloxacillin is more acid-stable than many other penicillins and can be given orally, in addition to [[parenteral]] routes. However, like [[methicillin]], it is less potent than [[benzylpenicillin]] against non-β-lactamase-producing [[Gram-positive]] bacteria. |
Dicloxacillin is more acid-stable than many other penicillins and can be given orally, in addition to [[parenteral]] routes. However, like [[methicillin]], it is less potent than [[benzylpenicillin]] against non-β-lactamase-producing [[Gram-positive]] bacteria. |
||
Dicloxacillin has similar [[pharmacokinetics]], antibacterial activity, and indications to flucloxacillin, and the two agents are considered interchangeable. It is believed to have lower incidence of severe hepatic [[adverse effect (medicine)|adverse effects]] than flucloxacillin, but a higher incidence of renal adverse effects.<ref name="rossi" /> |
Dicloxacillin has similar [[pharmacokinetics]], antibacterial activity, and indications to flucloxacillin, and the two agents are considered interchangeable. It is believed to have lower incidence of severe hepatic [[adverse effect (medicine)|adverse effects]] than flucloxacillin, but a higher incidence of renal adverse effects.<ref name="rossi">Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006</ref> |
||
Dicloxacillin is used for the treatment of infections caused by susceptible bacteria. Specific approved indications include:<ref name="rossi" /> |
Dicloxacillin is used for the treatment of infections caused by susceptible bacteria. Specific approved indications include:<ref name="rossi" /> |
||
Line 64: | Line 64: | ||
===Available forms=== |
===Available forms=== |
||
Dicloxacillin is commercially available as the sodium salt |
Dicloxacillin is commercially available as the sodium salt '''dicloxacillin sodium''' in capsules and as a powder for reconstitution.<ref name=":0" /> |
||
its also available as name of novaclox. |
|||
==Contraindications== |
==Contraindications== |
||
Dicloxacillin is contraindicated in those with a previous history of allergy to |
Dicloxacillin is contraindicated in those with a previous history of allergy (hypersensitivity/anaphylactic reaction) to any penicillins.<ref name=":0" /> It should also not be used in the eye, or those with a history of cholestatic hepatitis associated with the use of dicloxacillin or flucloxacillin. |
||
It should be used with caution in the elderly; renal impairment does not need dose adjustment<Bennett WM, Aronoff GR, Golper TA et al: Drug Prescribing in Renal Failure. American College of Physicians, 3rd ed, Philadelphia, PA, 1994 |
It should be used with caution in the elderly; renal impairment does not need dose adjustment, while those with hepatic impairment do, due to the risk of cholestatic hepatitis.<ref name="rossi" /><ref>Bennett WM, Aronoff GR, Golper TA et al: Drug Prescribing in Renal Failure. American College of Physicians, 3rd ed, Philadelphia, PA, 1994</ref> |
||
Dicloxacillin is Pregnancy Category B-with no conclusive studies about its fetal effects; however, penicillins do show up in breast milk and caution should be taken in nursing women.<ref name=":0" /> |
|||
==Adverse effects== |
==Adverse effects== |
Revision as of 01:04, 4 November 2015
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a685017 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 60 to 80% |
Protein binding | 98% |
Metabolism | Hepatic |
Elimination half-life | 0.7 hours |
Excretion | Renal and biliary |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.019.535 |
Chemical and physical data | |
Formula | C19H17Cl2N3O5S |
Molar mass | 470.327 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Dicloxacillin (INN) is a narrow-spectrum β-Lactam antibiotic of the penicillin class. It is used to treat infections caused by susceptible Gram-positive bacteria.[1] It is active against beta-lactamase-producing organisms such as Staphylococcus aureus,[2] which would otherwise be resistant to most penicillins. Dicloxacillin is available under a variety of trade names including Diclocil (BMS).
Medical uses
Dicloxacillin is more acid-stable than many other penicillins and can be given orally, in addition to parenteral routes. However, like methicillin, it is less potent than benzylpenicillin against non-β-lactamase-producing Gram-positive bacteria.
Dicloxacillin has similar pharmacokinetics, antibacterial activity, and indications to flucloxacillin, and the two agents are considered interchangeable. It is believed to have lower incidence of severe hepatic adverse effects than flucloxacillin, but a higher incidence of renal adverse effects.[3]
Dicloxacillin is used for the treatment of infections caused by susceptible bacteria. Specific approved indications include:[3]
- Staphylococcal skin infections and cellulitis – including impetigo, otitis externa, folliculitis, boils, carbuncles, and mastitis
- Pneumonia (adjunct)
- Osteomyelitis, septic arthritis, throat infections, streptococcus
- Septicaemia
- Empirical treatment for endocarditis
- Surgical prophylaxis
Available forms
Dicloxacillin is commercially available as the sodium salt dicloxacillin sodium in capsules and as a powder for reconstitution.[1]
Contraindications
Dicloxacillin is contraindicated in those with a previous history of allergy (hypersensitivity/anaphylactic reaction) to any penicillins.[1] It should also not be used in the eye, or those with a history of cholestatic hepatitis associated with the use of dicloxacillin or flucloxacillin.
It should be used with caution in the elderly; renal impairment does not need dose adjustment, while those with hepatic impairment do, due to the risk of cholestatic hepatitis.[3][4]
Dicloxacillin is Pregnancy Category B-with no conclusive studies about its fetal effects; however, penicillins do show up in breast milk and caution should be taken in nursing women.[1]
Adverse effects
Common adverse drug reactions (ADRs) associated with the use of dicloxacillin include: diarrhoea, nausea, rash, urticaria, pain and inflammation at injection site, superinfection (including candidiasis), allergy, and transient increases in liver enzymes and bilirubin.[3]
On rare occasions, cholestatic jaundice (also referred to as cholestatic hepatitis) has been associated with dicloxacillin therapy. The reaction may occur up to several weeks after treatment has stopped, and takes weeks to resolve. The estimated incidence is 1 in 15,000 exposures, and is more frequent in people >55 years, females, and those with treatment longer than 2 weeks.[3]
Resistance
Despite dicloxacillin's being insensitive to beta-lactamases, some organisms have developed resistance to it and other narrow-spectrum β-lactam antibiotics including methicillin. Such organisms include methicillin-resistant Staphylococcus aureus (MRSA).
Mechanism of action
Like other β-Lactam antibiotics, dicloxacillin acts by inhibiting the synthesis of bacterial cell walls. It inhibits cross-linkage between the linear peptidoglycan polymer chains that make up a major component of the cell wall of Gram-positive bacteria.
Medicinal chemistry
Dicloxacillin is insensitive to beta-lactamase (also known as penicillinase) enzymes secreted by many penicillin-resistant bacteria. The presence of the isoxazolyl group on the side chain of the penicillin nucleus facilitates the β-lactamase resistance, since they are relatively intolerant of side-chain steric hindrance. Thus, it is able to bind to penicillin-binding proteins (PBPs) and inhibit peptidoglycan crosslinking, but is not bound by or inactivated by β-lactamases.
See also
- Beta-lactam antibiotic
- Flucloxacillin
- Amoxicillin (formerly Beecham, now GlaxoSmithKline)
References
- ^ a b c d Product Information: DICLOXACILLIN SODIUM-dicloxacillin sodium capsule. Teva Pharmaceuticals USA Inc, Revised 8/2015
- ^ Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F (2006). "In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains". Ann. Clin. Microbiol. Antimicrob. 5: 25. doi:10.1186/1476-0711-5-25. PMC 1617116.PMID 17034644.
- ^ a b c d e Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006
- ^ Bennett WM, Aronoff GR, Golper TA et al: Drug Prescribing in Renal Failure. American College of Physicians, 3rd ed, Philadelphia, PA, 1994